±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 365  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

תÉíØ¼Íü²»µô

Í­³æ (СÓÐÃûÆø)

[ÇóÖú] Ó¢ÓïÂÛÎÄ·­Ò룬ÇóÖú£¡

Polymer scaffolds, particularly in the form of microspheres, have been employed to support cells growth and deliver drugs or growth factors in tissue engineering. In this study, we have established a scaffold by embedding poly (¦Â-hydroxybutyrate-co-¦Â-hydroxyvalerate) (PHBV) microspheres into poly (L-lactic-coglycolic acid) (PLGA£©matrix, according to their different solubility in acetone, with the aim of repairing bone defects. PLGA/PHBV scaffolds had good pore parameters, for example, the porosity of PLGA/30% PHBV scaffold can reach to 81.273 ¡À 2.192%. Besides, the pore size distribution of the model was evaluated and the results revealed that the pore size mainly distributed between 50 ¦Ìm and 200 ¦Ìm. With increasing the amount of PHBV microspheres, the compressive strength of the PLGA/PHBV scaffold enhanced. The morphology of the hybrid scaffold was rougher than that of pure PLGA scaffold, which had no significant effect on the cell behavior. The in vitro evaluation suggested that the model is suitable as a scaffold for engineering bone tissue, and has the potential for further applications in drug delivery system.


» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

phu_grassman

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

¿ìÀÖµº¡¢²¼¼ªµºµºÖ÷

ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
תÉíØ¼Íü²»µô: ½ð±Ò+7, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, °ô£¡ 2014-11-21 10:58:31
¸ß·Ö×ÓÖ§¼Ü£¬ÌرðÊÇ΢ÇòÐÎʽµÄÖ§¼Ü£¬ÒÑÔÚ×éÖ¯¹¤³ÌÖб»ÓÃÀ´Ö§³Åϸ°ûÉú³¤ÒÔ¼°ÊÍ·ÅÒ©Îï»òÉú³¤Òò×Ó¡£ÔÚ±¾Ñо¿ÖУ¬ÎªÁËÐÞ¸´¹ÇËðÉË£¬ÎÒÃÇ·¢Õ¹ÁËÒ»ÖÖÖÆ±¸Ö§¼Ü·½·¨£¬¼´¸ù¾ÝÆäÔÚ±ûͪÖÐÈܽâÐԵIJîÒ죬½«£Ð£È£Â£Ö΢Çò°üÂñÔڣУ̣ǣÁ»ùÖÊÖС££Ð£Ì£Ç£Á£¯£Ð£È£Â£ÖÖ§¼Ü¾ßÓÐÁ¼ºÃµÄ¿×²ÎÊý£¬ÀýÈ磬£Ð£Ì£Ç£Á£¯£³£°£¥£Ð£È£Â£ÖÖ§¼ÜµÄ¶à¿×ÐÔ¿É´ï81.273 ¡À  2.192%¡£Í¬Ê±£¬ÎÒÃÇÒ²ÆÀ¹ÀÁËÕâһģÐ͵Ŀ׾¶·Ö²¼£¬½á¹û±íÃ÷¿×¾¶Ö÷Òª·Ö²¼ÔÚ£µ£°¡« 200 ¦Ìm·¶Î§¡£Í¨¹ýÔö¼Ó£Ð£È£Â£Ö΢ÇòÁ¿£¬´Ë¸ß·Ö×ÓÖ§¼ÜµÄ¿¹Ñ¹Ç¿¶ÈÔöÇ¿ÁË¡£ÕâÖÖ»ìºÏÐÍÖ§¼ÜµÄÐÎò±ðµ¥´¿µÄ£Ð£Ì£Ç£ÁÖ§¼Ü´Ö²Ú£¬¶øÕâÒ»±ä»¯¶Ôϸ°ûÐÐΪûÓÐÏÔÖøÓ°Ïì¡£ÌåÍâÆÀ¹À±íÃ÷ÕâÖÖÄ£ÐÍÊÊÓÃÓÚ¹¤³Ì¹Ç×éÖ¯ÖеÄÖ§¼Ü£¬²¢ÇÒÔÚÒ©ÎïÊÍ·ÅϵͳµÄ½øÒ»²½Ó¦ÓÃÖоßÓкܴóDZÁ¦¡£
2Â¥2014-11-21 10:29:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ תÉíØ¼Íü²»µô µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏ334Çóµ÷¼Á +15 Eecho# 2026-04-03 15/750 2026-04-04 23:05 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ìµ÷¼Á +19 ÉîVËÞÉá°É 2026-03-30 20/1000 2026-04-04 22:13 by hemengdong
[¿¼ÑÐ] 358Çóµ÷¼Á +5 Çïgk 2026-04-04 5/250 2026-04-04 21:03 by dongzh2009
[¿¼ÑÐ] µ÷¼Á +4 ÊÇ¿ÉÀÖ²»ÊÇ¿ÉÀÖ 2026-04-04 4/200 2026-04-04 19:41 by ÌÆãå¶ù
[¿¼ÑÐ] 363Çóµ÷¼Á +7 zh096 2026-04-04 7/350 2026-04-04 17:13 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì302µ÷¼Á»·»¯»ò»¯¹¤ +19 Doleres 2026-03-31 20/1000 2026-04-04 16:44 by °¡¿¡£¡
[¿¼ÑÐ] 081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ +15 ÅûÐÇºÓ 2026-04-03 15/750 2026-04-04 16:25 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ²ÄÁϹ¤³Ì085601£¬Çóµ÷¼Á +17 cdyw 2026-04-02 18/900 2026-04-04 11:14 by w_xuqing
[¿¼ÑÐ] »úеר˶297 +3 Afksy 2026-04-03 3/150 2026-04-03 14:24 by 1753564080
[¿¼ÑÐ] 372·Ö²ÄÁÏÓ뻯¹¤£¨085600£©Ò»Ö¾Ô¸ºþÄÏ´óѧÇóµ÷¼Á +5 À¶¼ãƬ 2026-04-02 6/300 2026-04-02 21:37 by dongzh2009
[¿¼ÑÐ] Çóµ÷¼Á 302·Ö³õÊÔ 0854 +5 Áæ¿ÉÀÖ 2026-04-02 5/250 2026-04-02 17:53 by ±ÊÂä½õÖÝ
[¿¼ÑÐ] 311Çóµ÷¼Á +14 À¶ÔÂÁÁÁÁ 2026-03-30 14/700 2026-04-02 12:18 by 1753564080
[¿¼ÑÐ] 327Çóµ÷¼Á +9 ¼³Òàê» 2026-03-29 9/450 2026-04-02 11:44 by ÔËÆøyunqi
[¿¼ÑÐ] Ò»Ö¾Ô¸9³õÊÔ366 ±¾Ë«·ÇÇóµ÷¼Á +4 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 4/200 2026-04-02 09:56 by guanxin1001
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +12 Ò»ÑùYWY 2026-04-01 12/600 2026-04-02 00:21 by °ÙÃë¹âÄê
[¿¼²©] 26ÄêÉ격 +3 staryer 2026-03-30 4/200 2026-04-01 23:21 by ai4pharm
[¿¼ÑÐ] 311Çóµ÷¼Á +10 ÀîÜÆÐÂ1 2026-03-31 10/500 2026-04-01 14:38 by chenqifeng666
[¿¼ÑÐ] 267Çóµ÷¼Á +13 uiybh 2026-03-31 13/650 2026-04-01 10:25 by ̽123
[¿¼ÑÐ] 358Çóµ÷¼Á +3 ÍõÏòÑô»¨ 2026-03-31 3/150 2026-04-01 09:56 by zzchen2000
[¿¼ÑÐ] 339Çóµ÷¼Á +5 zjjkt 2026-03-31 5/250 2026-04-01 09:18 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û